Compare NATR & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NATR | SERA |
|---|---|---|
| Founded | 1972 | 2008 |
| Country | United States | United States |
| Employees | 806 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.7M | 75.2M |
| IPO Year | 1995 | 2021 |
| Metric | NATR | SERA |
|---|---|---|
| Price | $22.41 | $1.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $28.33 | N/A |
| AVG Volume (30 Days) | ★ 68.0K | 36.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.00 | 32.32 |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $480,144,000.00 | $81,000.00 |
| Revenue This Year | $7.76 | $554.81 |
| Revenue Next Year | $4.82 | $517.27 |
| P/E Ratio | $76.81 | ★ N/A |
| Revenue Growth | ★ 5.67 | 5.19 |
| 52 Week Low | $12.97 | $1.37 |
| 52 Week High | $28.14 | $4.09 |
| Indicator | NATR | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 27.22 | 39.36 |
| Support Level | $21.27 | N/A |
| Resistance Level | $27.74 | $2.41 |
| Average True Range (ATR) | 1.22 | 0.22 |
| MACD | -0.47 | -0.02 |
| Stochastic Oscillator | 15.77 | 23.73 |
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.